Combination of BRAF Inhibitors and Brain Radiotherapy in Patients With Metastatic Melanoma Shows Minimal Acute Toxicity-Reference-Cited by-同舟云学术

Combination of BRAF Inhibitors and Brain Radiotherapy in Patients With Metastatic Melanoma Shows Minimal Acute Toxicity

Published:2013-10-20 Issue:30 Volume:31 Page:3844-3845
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Rompoti Natalia¹,Schilling Bastian¹,Livingstone Elisabeth¹,Griewank Klaus¹,Hillen Uwe¹,Sauerwein Wolfgang²,Pöttgen Christoph²,Stuschke Martin²,Schadendorf Dirk¹,Zimmer Lisa¹

Affiliation:

1. University Hospital Essen, University Duisburg-Essen, Essen, Germany

2. West German Cancer Center Essen, University Hospital Essen, University Duisburg-Essen, Essen, Germany

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2013.50.8473

Reference6 articles.

1. Serious Skin Toxicity With the Combination of BRAF Inhibitors and Radiotherapy

2. Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial

3. Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial

4. Melanoma cells show a heterogeneous range of sensitivity to ionizing radiation and are radiosensitized by inhibition of B-RAF with PLX-4032

5. Vemurafenib and radiation therapy in melanoma brain metastases

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of melanoma central nervous system metastases;Oncology in Clinical Practice;2023-10-17

2. Targeting RAS–RAF–MEK–ERK signaling pathway in human cancer: Current status in clinical trials;Genes & Diseases;2023-01

3. Drug-Specific Orofacial Complications of Novel Anti-cancer Therapies;Orofacial Supportive Care in Cancer;2022

4. Safety of radiosurgery concurrent with systemic therapy (chemotherapy, targeted therapy, and/or immunotherapy) in brain metastases: a systematic review;Cancer and Metastasis Reviews;2021-01-04

5. Dabrafenib and Trametinib;New Therapies in Advanced Cutaneous Malignancies;2021